The GoodRx Pharmacist - June 22, 2017
Watch out EpiPen there’s (another) new kid on the block. On June 15, 2017, Adamis Pharmaceuticals received FDA approval for Symjepi, their new epinephrine injection. Symjepi joins Adrenaclick, Auvi-Q, and others as an alternative to the expensive treatment for severe allergic reactions. Adamis also anticipates a low cost for the life-saving medication.
Tori Marsh - January 20, 2017
You might be tired of hearing about the EpiPen pricing controversy after the past couple of months. In 2016, it felt like the the life-saving epinephrine auto-injector would never be affordable, as even generic epinephrine was priced around $300.
Tori Marsh - December 22, 2016
After months of waiting, we finally have some good news for EpiPen users! On December 16th, Mylan announced that epinephrine, the generic for the expensive EpiPen auto-injector, will be available in pharmacies this week.
As you may have heard, over the past couple of months, Mylan Pharmaceuticals, the manufacturer of EpiPen, has been criticized for increasing the price of the epinephrine auto-injector by 400% since 2007, to about $600. See More
Tori Marsh - October 26, 2016
Amidst the recent drama surrounding EpiPen prices, we finally have some good news for epinephrine auto-injectors. The expensive Epipen, and EpiPen Jr, will soon have more competition!
In 2017, manufacturer Kaleo will be re-releasing Auvi-Q, their brand of the epinephrine auto-injector. Auvi-Q was pulled from the market last year, but Kaleo has bought back the rights, and plans to release the alternative auto-injector within the next year. See More
The GoodRx Pharmacist - November 04, 2015
Manufacturer Sanofi has issued a voluntary recall of four lots of Auvi-Q (epinephrine), an injection used to treat life-threatening allergic reactions. Auvi-Q is one of the newer epinephrine injections available, with a device that has the ability to talk you through each step of the injection.
This is a class II recall, the most common type of recall, which means that there is a situation where use of the recalled medication may cause temporary or medically reversible adverse health consequences, but the likelihood of serious adverse effects is small. See More
The GoodRx Pharmacist - September 08, 2015
Get those lunches made and set the alarm clocks; school’s back in session.
Parents know that a new school year means new clothes, new books, maybe a new backpack—and perhaps a new set of prescriptions. As a pharmacist, I know the school year has started when frustrated parents show up at my store with lots of questions.
The good news is that I can help! Here are 5 helpful solutions for common back-to-school medication issues. See More
Elizabeth Davis - April 10, 2015
As you may know from experience, or from one of our previous articles on changes in coverage in 2014 or 2015, it’s typical for prescription benefit managers (PBMs) to exclude medications from their national preferred formularies each year. These may be brands that have generics available, or generally expensive medications where your plan feels a cheaper alternative may work just as well.
It’s less likely that existing drugs will be added back to the preferred formulary (or at least removed from the exclusion list), but that happened this year in several cases for Express Scripts and Caremark—two major PBMs. See More
The GoodRx Pharmacist - June 13, 2014
When the sun finally comes out and the weather starts to change, you can tell that summer is nearby. It’s a great time to spend more time outside, but you may be more prone to summertime illnesses and injuries like allergies, insect bites, sunburns, rashes, cuts and scrapes, dehydration, and asthma. Here are some things to watch out for:
It can sometimes be difficult to do outdoor activities in the hot summer sun even if you don’t have asthma or breathing problems—if you do have asthma, you’ll want to be extra careful. See More
The GoodRx Pharmacist - December 23, 2013
Express Scripts and Caremark have removed certain medications from their formulary starting in January 2014. These companies handle prescription benefits for more than 200 million Americans, so your prescription coverage will likely be changing in the new year.
We’re reviewing which prescriptions will no longer be covered and the suggested alternatives to give you a better picture of your options. Express Scripts has made a change in their coverage of emergency allergic reaction meds that may affect you:
Removed medication: Auvi-Q || Suggested Alternatives: EpiPen, EpiPen Jr
Auvi-Q is the new injectable that literally talks you through the injection process if you are having an anaphylactic allergic reaction. See More
Elizabeth Davis - October 29, 2013
For many Americans with health insurance, more than 50 popular brand-name drugs may no longer be covered starting in January 2014. Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing almost 50 brands from their formularies at the end of 2013. More information is below.
What are Express Scripts and Caremark?
Express Scripts and Caremark are companies that administer prescription drug benefits for many health insurance companies and Tricare. See More